[Retracted] Proteasome inhibitors in glioblastoma (Review)
- Authors:
- Published online on: September 8, 2017 https://doi.org/10.3892/ol.2017.6921
- Pages: 6321-6321
-
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article
Oncol Lett 13: [Related article:] 1058-1062, 2017; DOI: 10.3892/ol.2017.5585
Further to the publication of the above review article, the Editor of Oncology Letters was contacted by an interested reader who drew to our attention that an extensive overlap existed between the text of the review and the doctoral dissertion, ‘Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma.’ 2015/05 http://digitalcommons.library.tmc.edu/utgsbs_dissertations/545/.
Following an investigation, the journal is able to confirm that parts from the review are identical with those featured in the 2015 dissertation. On those grounds, we are retracting the review from the publication. The Editor deeply regrets any inconvenience that this retraction has caused to the readership of the Journal.
